These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35960940)

  • 1. Detecting and Managing ASCVD in Women: A Focus on Statins.
    Kushner P
    J Fam Pract; 2022 Jul; 71(6 Suppl):S17-S22. PubMed ID: 35960940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents.
    Hiles M; Simmons A; Hilleman D; Gibson CA; Backes JM
    Clin Ther; 2023 Nov; 45(11):1127-1136. PubMed ID: 37770308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
    Malvestutto C
    J Fam Pract; 2022 Jul; 71(6 Suppl):S58-S62. PubMed ID: 35960946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
    Berman AN; Blankstein R
    Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy for young adults: A long-term investment worth considering.
    Miedema MD; Nauffal VD; Singh A; Blankstein R
    Trends Cardiovasc Med; 2020 Jan; 30(1):48-53. PubMed ID: 30808553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins.
    Kawada T
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):569-570. PubMed ID: 34767132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].
    Lucchi T; Vergani C
    G Ital Cardiol (Rome); 2014 Mar; 15(3):149-60. PubMed ID: 24770428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.
    Al Rifai M; Blumenthal RS; Stone NJ; Schofield RS; Orringer CE; Michos ED; Heidenreich PA; Braun L; Birtcher KK; Smith SC; Nambi V; Grundy S; Virani SS
    Prog Cardiovasc Dis; 2021; 68():2-6. PubMed ID: 34371083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy in midlife women.
    Shufelt CL
    Menopause; 2021 Jul; 28(9):1067-1069. PubMed ID: 34284431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus.
    Tan M; MacEachern MP
    Clin Geriatr Med; 2020 Aug; 36(3):457-476. PubMed ID: 32586475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Heart Federation Cholesterol Roadmap 2022.
    Ray KK; Ference BA; Séverin T; Blom D; Nicholls SJ; Shiba MH; Almahmeed W; Alonso R; Daccord M; Ezhov M; Olmo RF; Jankowski P; Lanas F; Mehta R; Puri R; Wong ND; Wood D; Zhao D; Gidding SS; Virani SS; Lloyd-Jones D; Pinto F; Perel P; Santos RD
    Glob Heart; 2022; 17(1):75. PubMed ID: 36382159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2022 Taiwan lipid guidelines for primary prevention.
    Huang PH; Lu YW; Tsai YL; Wu YW; Li HY; Chang HY; Wu CH; Yang CY; Tarng DC; Huang CC; Ho LT; Lin CF; Chien SC; Wu YJ; Yeh HI; Pan WH; Li YH;
    J Formos Med Assoc; 2022 Dec; 121(12):2393-2407. PubMed ID: 35715290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.